BRIEF published on 07/24/2024 at 10:05, 3 months 28 days ago Fiven ASA Announces Redemption of Bonds Fiven ASA Nasdaq Stockholm Change Of Control Sustainability-Linked Bonds Bond Redemption
PRESS RELEASE published on 07/24/2024 at 10:00, 3 months 28 days ago Fiven ASA announces redemption of bonds Fiven ASA announces redemption of EUR 110,000,000 senior secured sustainability-linked floating rate bonds according to the Terms and Conditions, with a redemption date of 31 July 2024 Fiven ASA Terms And Conditions Change Of Control Redemption Sustainability-Linked Bonds
BRIEF published on 07/15/2024 at 16:05, 4 months 5 days ago Fiven ASA Publishes Sustainability-Linked Bond Progress Report Fiven ASA Sustainability-linked Bond Redemption Progress Report
PRESS RELEASE published on 07/15/2024 at 16:00, 4 months 5 days ago New Sustainability-linked bond progress report Fiven ASA releases sustainability-linked bond progress report in compliance with bond terms and conditions. Redemption of EUR 110,000,000 senior secured bonds planned Fiven ASA Sustainability-linked Bond Redemption Progress Report Bond Terms And Conditions
BRIEF published on 06/21/2024 at 18:20, 4 months 29 days ago Fiven ASA Announces Plan to Redeem EUR 110m Bonds Acquisition Fiven ASA Redemption EUR 110m Bonds
PRESS RELEASE published on 06/21/2024 at 18:15, 4 months 29 days ago Intention to redeem outstanding EUR 110m bonds Fiven ASA intends to redeem its outstanding EUR 110m bonds following the acquisition by Kymera International, LLC, a portfolio company of Palladium Equity Partners, LLC Acquisition Fiven ASA Redemption Kymera International EUR 110m Bonds
BRIEF published on 06/05/2024 at 07:50, 5 months 16 days ago Binding Agreement for the Sale of Fiven Acquisition Silicon Carbide Fiven OpenGate Capital Kymera International
PRESS RELEASE published on 06/05/2024 at 07:45, 5 months 16 days ago Binding agreement for the sale of Fiven Fiven ASA announces binding agreement for sale to Kymera International. OpenGate Capital sells Fiven, a leading producer of Silicon Carbide, to Palladium Equity Partners' portfolio company. Transaction subject to regulatory approvals Sale Fiven ASA Silicon Carbide Binding Agreement Palladium Equity Partners
BRIEF published on 05/24/2024 at 10:25, 5 months 28 days ago Fiven ASA Reports First Quarter Results 2024 EBITDA Revenue Cash Flow Quarter Results Fiven ASA
PRESS RELEASE published on 05/24/2024 at 10:20, 5 months 28 days ago Fiven ASA - First Quarter Results 2024 Fiven ASA announces First Quarter Results for 2024 with total revenues of EUR 35.2m and adjusted EBITDA of EUR 10.5m. Cash flow impacted by one-off change in working capital Revenues EBITDA Cash Flow Fiven ASA First Quarter Results
Published on 11/21/2024 at 14:15, 20 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 35 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 35 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 35 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 19 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 20 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 2 hours ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 37 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 15 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 50 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 50 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
